{"id":456772,"date":"2021-03-12T08:33:30","date_gmt":"2021-03-12T13:33:30","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=456772"},"modified":"2021-03-12T08:33:30","modified_gmt":"2021-03-12T13:33:30","slug":"brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\/","title":{"rendered":"Brain Scientific Featured in Syndicated Broadcast Covering Receipt of FDA Clearance for Next-Gen NeuroCap EEG Headset"},"content":{"rendered":"
\n

NEW YORK, March 12, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Brain Scientific Inc.<\/strong><\/a>\u00a0<\/strong><\/a>(OTCQB:\u00a0<\/strong>BRSF<\/strong><\/a>\u00a0<\/strong><\/a>)<\/strong> today announces it has been featured in a broadcast via NetworkNewsAudio (NNA), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio press release covers Brain Scientific\u2019s receipt of U.S. Food and Drug Administration (\u201cFDA\u201d) 510(k) clearance for its next-generation NeuroCap\u2122 device. NeuroCap\u2122 is an advanced Electroencephalogram (EEG) electrode array used to obtain rapid EEGs in routine clinical and research settings where recording of STAT EEGs is desired.<\/p>\n

To hear the audio production, visit:\u00a0https:\/\/nnw.fm\/um28X<\/a><\/p>\n

To read the original press release, visit:\u00a0https:\/\/nnw.fm\/TgVmq<\/a><\/p>\n

\u201cWe are constantly working on new products for the EEG market. In the new version of\u00a0NeuroCap\u2122,\u00a0<\/a>we added velcro strips for better adhesion. We also expanded the size range by adding an XS (extra small) size. And now this device is designed for broader use \u2013 in addition to intensive care units and ERs,\u201d\u00a0said Irina Nazarova, marketing director at\u00a0<\/strong>Brain Scientific.<\/p>\n

NeuroCap\u2122 is a disposable pre-gelled EEG headset with 22 electrodes and 19 active EEG channels located in accordance with the 10-20 system. Pre-gelled, fixed electrode locations eliminate time-consuming tasks of head measurement and electrode placement. The cap is FDA-cleared to stay on a patient\u2019s head for up to four hours. NeuroCap\u2122 is compatible with most encephalographs on the market and can be applied in just five minutes.<\/p>\n

\n About Brain Scientific<\/strong>
\n
\n Brain Scientific\u00a0<\/a>is a commercial-stage healthcare company with two FDA-cleared products, providing next-gen solutions to the neurology market. The Company\u2019s smart diagnostic devices and sensors simplify administration, shorten scan time and cut costs, allowing clinicians to make rapid decisions and bridge the widening gap in access to neurological care.<\/p>\n

For more information, visit the company\u2019s website at www.brainscientific.com<\/a>.<\/p>\n

\n About NetworkNewsAudio<\/strong>\n <\/p>\n

NetworkNewsAudio (\u201cNNA\u201d), one of 50+ brands within the\u00a0InvestorBrandNetwork\u00a0<\/u><\/a>(\u201cIBN\u201d), allows you to sit back and listen to market updates, CEO interviews and\u00a0AudioPressRelease (\u201cAPR\u201d)<\/u>\u00a0<\/a>productions. These audio clips provide snapshots of position, opportunity and momentum. NNA can assist by cutting through the overload of information in today’s market, while bringing its clients unparalleled visibility, recognition and brand awareness. IBN is where news, content and information converge. IBN is a comprehensive provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, IBN has the unparalleled ability to reach a wide audience of investors, consumers, journalists and the general public with an ever-growing distribution network of 5,000+ key syndication outlets across the nation.<\/p>\n

For more information, visit:\u00a0www.NetworkNewsAudio.com<\/u><\/a>.<\/p>\n

Please see full terms of use and disclaimers on the InvestorBrandNetwork website, applicable to all content provided by IBN wherever published or re-published:\u00a0http:\/\/IBN.fm\/Disclaimer<\/u><\/a><\/p>\n

\n Forward-Looking Statements<\/strong><\/p>\n

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements, which involve assumptions and describe our future plans, strategies and expectations, are generally identifiable by use of the words \u201cmay,\u201d \u201cshould,\u201d \u201cwould,\u201d \u201cwill,\u201d \u201ccould,\u201d \u201cscheduled,\u201d \u201cexpect,\u201d \u201canticipate,\u201d \u201cestimate,\u201d \u201cbelieve,\u201d \u201cintend,\u201d \u201cseek\u201d or \u201cproject\u201d or the negative of these words or other variations on these words or comparable terminology. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances, and may not be realized because they are based upon the Company’s current projections, plans, objectives, beliefs, expectations, estimates and assumptions, and are subject to several risks and uncertainties and other influences, over many of which the Company has no control. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the Company’s inability to obtain additional financing, the significant length of time and resources associated with the development of our products and related insufficient cash flows and resulting illiquidity, the Company’s inability to expand its business, significant government regulation of medical devices and the healthcare industry, lack of product diversification, volatility in the price of the Company’s raw materials and the Company’s failure to implement the Company’s business plans or strategies. These and other factors are identified and described in more detail in the Company’s filings with the SEC. The Company does not undertake to update these forward-looking statements.<\/p>\n

\n Corporate Communications:<\/strong>\n <\/p>\n

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com<\/u><\/a>
310.299.1717 Office
Editor@InvestorBrandNetwork.com<\/u><\/a><\/p>\n<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, March 12, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Brain Scientific Inc.\u00a0(OTCQB:\u00a0BRSF\u00a0) today announces it has been featured in a broadcast via NetworkNewsAudio (NNA), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio press release covers Brain Scientific\u2019s receipt of U.S. Food and Drug Administration (\u201cFDA\u201d) 510(k) clearance for its next-generation NeuroCap\u2122 device. NeuroCap\u2122 is an advanced Electroencephalogram (EEG) electrode array used to obtain rapid EEGs in routine clinical and research settings where recording of STAT EEGs is desired. To hear the audio production, visit:\u00a0https:\/\/nnw.fm\/um28X To read the original press release, visit:\u00a0https:\/\/nnw.fm\/TgVmq \u201cWe are constantly working on new products for the EEG market. In … <\/p>\n

Continue reading “Brain Scientific Featured in Syndicated Broadcast Covering Receipt of FDA Clearance for Next-Gen NeuroCap EEG Headset”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-456772","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBrain Scientific Featured in Syndicated Broadcast Covering Receipt of FDA Clearance for Next-Gen NeuroCap EEG Headset - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Brain Scientific Featured in Syndicated Broadcast Covering Receipt of FDA Clearance for Next-Gen NeuroCap EEG Headset - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, March 12, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Brain Scientific Inc.\u00a0(OTCQB:\u00a0BRSF\u00a0) today announces it has been featured in a broadcast via NetworkNewsAudio (NNA), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio press release covers Brain Scientific\u2019s receipt of U.S. Food and Drug Administration (\u201cFDA\u201d) 510(k) clearance for its next-generation NeuroCap\u2122 device. NeuroCap\u2122 is an advanced Electroencephalogram (EEG) electrode array used to obtain rapid EEGs in routine clinical and research settings where recording of STAT EEGs is desired. To hear the audio production, visit:\u00a0https:\/\/nnw.fm\/um28X To read the original press release, visit:\u00a0https:\/\/nnw.fm\/TgVmq \u201cWe are constantly working on new products for the EEG market. In … Continue reading "Brain Scientific Featured in Syndicated Broadcast Covering Receipt of FDA Clearance for Next-Gen NeuroCap EEG Headset"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-12T13:33:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4ODk4MyM0MDYxMDg1IzUwMDA3NTYzMg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Brain Scientific Featured in Syndicated Broadcast Covering Receipt of FDA Clearance for Next-Gen NeuroCap EEG Headset\",\"datePublished\":\"2021-03-12T13:33:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\\\/\"},\"wordCount\":794,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4ODk4MyM0MDYxMDg1IzUwMDA3NTYzMg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\\\/\",\"name\":\"Brain Scientific Featured in Syndicated Broadcast Covering Receipt of FDA Clearance for Next-Gen NeuroCap EEG Headset - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4ODk4MyM0MDYxMDg1IzUwMDA3NTYzMg==\",\"datePublished\":\"2021-03-12T13:33:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4ODk4MyM0MDYxMDg1IzUwMDA3NTYzMg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4ODk4MyM0MDYxMDg1IzUwMDA3NTYzMg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Brain Scientific Featured in Syndicated Broadcast Covering Receipt of FDA Clearance for Next-Gen NeuroCap EEG Headset\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Brain Scientific Featured in Syndicated Broadcast Covering Receipt of FDA Clearance for Next-Gen NeuroCap EEG Headset - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\/","og_locale":"en_US","og_type":"article","og_title":"Brain Scientific Featured in Syndicated Broadcast Covering Receipt of FDA Clearance for Next-Gen NeuroCap EEG Headset - Market Newsdesk","og_description":"NEW YORK, March 12, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Brain Scientific Inc.\u00a0(OTCQB:\u00a0BRSF\u00a0) today announces it has been featured in a broadcast via NetworkNewsAudio (NNA), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio press release covers Brain Scientific\u2019s receipt of U.S. Food and Drug Administration (\u201cFDA\u201d) 510(k) clearance for its next-generation NeuroCap\u2122 device. NeuroCap\u2122 is an advanced Electroencephalogram (EEG) electrode array used to obtain rapid EEGs in routine clinical and research settings where recording of STAT EEGs is desired. To hear the audio production, visit:\u00a0https:\/\/nnw.fm\/um28X To read the original press release, visit:\u00a0https:\/\/nnw.fm\/TgVmq \u201cWe are constantly working on new products for the EEG market. In … Continue reading \"Brain Scientific Featured in Syndicated Broadcast Covering Receipt of FDA Clearance for Next-Gen NeuroCap EEG Headset\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-12T13:33:30+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4ODk4MyM0MDYxMDg1IzUwMDA3NTYzMg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Brain Scientific Featured in Syndicated Broadcast Covering Receipt of FDA Clearance for Next-Gen NeuroCap EEG Headset","datePublished":"2021-03-12T13:33:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\/"},"wordCount":794,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4ODk4MyM0MDYxMDg1IzUwMDA3NTYzMg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\/","name":"Brain Scientific Featured in Syndicated Broadcast Covering Receipt of FDA Clearance for Next-Gen NeuroCap EEG Headset - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4ODk4MyM0MDYxMDg1IzUwMDA3NTYzMg==","datePublished":"2021-03-12T13:33:30+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4ODk4MyM0MDYxMDg1IzUwMDA3NTYzMg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4ODk4MyM0MDYxMDg1IzUwMDA3NTYzMg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brain-scientific-featured-in-syndicated-broadcast-covering-receipt-of-fda-clearance-for-next-gen-neurocap-eeg-headset\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Brain Scientific Featured in Syndicated Broadcast Covering Receipt of FDA Clearance for Next-Gen NeuroCap EEG Headset"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/456772","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=456772"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/456772\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=456772"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=456772"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=456772"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}